Terms: = Kidney tumors AND PAX8, ENSG00000125618, 7849 AND Prognosis
48 results:
1. Clear cell renal cell carcinoma with syncytial giant cells: Not that rare.
Sun W; Yue J; Fan L
Pathol Res Pract; 2024 Jan; 253():155043. PubMed ID: 38183816
[TBL] [Abstract] [Full Text] [Related]
2. [Clinicopathological features of intravascular large B-cell lymphoma and collision tumors of five cases].
Liu J; Liu GZ; Xia L; Wang HY; Zhang XF; Liu H
Zhonghua Bing Li Xue Za Zhi; 2024 Jan; 53(1):22-28. PubMed ID: 38178742
[No Abstract] [Full Text] [Related]
3. Clear cell urothelial carcinoma of bladder: Case report of a rare and aggressive variant with review of literature.
Sahetia KM; Dave VN; Pal M; Menon S
Indian J Cancer; 2023 Oct; 60(4):575-577. PubMed ID: 38145907
[TBL] [Abstract] [Full Text] [Related]
4. Advanced renal pelvis carcinoma patient with an ERBB2 insertion mutation: a case report.
Shang P; Lou C; Yin L; Tao C; Dong Y; Yang G; Yuan Z
J Int Med Res; 2023 Nov; 51(11):3000605231204502. PubMed ID: 37917812
[TBL] [Abstract] [Full Text] [Related]
5. Papillary renal neoplasm with reverse polarity: a clinicopathologic study of 43 cases with a focus on the expression of KRAS signaling pathway downstream effectors.
Kim B; Lee S; Moon KC
Hum Pathol; 2023 Dec; 142():1-6. PubMed ID: 37797754
[TBL] [Abstract] [Full Text] [Related]
6. Metastases to the kidney from primary lung cancer : clinicopathological analysis of six cases in a single center.
Lian H; Pan X; Hong B; Min J; Huang F
Diagn Pathol; 2023 May; 18(1):60. PubMed ID: 37161448
[TBL] [Abstract] [Full Text] [Related]
7. Chromophobe Renal Cell Carcinoma with Sarcomatoid Differentiation: Clinicopathologic Correlation and Molecular Findings.
Gama A; Xu H; Yang XJ; Choy B
Int J Surg Pathol; 2024 Feb; 32(1):11-16. PubMed ID: 37063043
[No Abstract] [Full Text] [Related]
8. Clear cell renal cell carcinoma with cystic component similar to multilocular cystic renal neoplasm of low malignant potential: a rare pattern of cyst-dependent progression from multilocular cystic renal neoplasm of low malignant potential.
Yang B; Sun L; Cao WF; Qi LS; Guo YH; Sun Y
Diagn Pathol; 2023 Feb; 18(1):27. PubMed ID: 36810118
[TBL] [Abstract] [Full Text] [Related]
9. [Oncocytic papillary renal cell carcinoma: a clinicopathological analysis of nineteen cases].
Zhang W; Zhang LX; Yang T; Zou YW; Liu XL; Yu WJ; Jiang YX; Li YJ
Zhonghua Bing Li Xue Za Zhi; 2022 Oct; 51(10):981-986. PubMed ID: 36207910
[No Abstract] [Full Text] [Related]
10. [Anaplastic lymphoma kinase-translocation renal cell carcinoma: clinical and pathological analysis].
Di SH; Wang XT; Xia QY; Lu ZF; Ma HH; Zhang RS; Wang X; Rao Q
Zhonghua Bing Li Xue Za Zhi; 2022 Jan; 51(1):28-32. PubMed ID: 34979750
[No Abstract] [Full Text] [Related]
11. Acquired cystic disease-associated renal cell carcinoma: A clinicopathologic study of eight tumors with clinical follow-up.
Chrabańska M; Ryszawy J; Drozdzowska B
Indian J Cancer; 2021; 58(4):608-614. PubMed ID: 34975102
[TBL] [Abstract] [Full Text] [Related]
12. Morphological, immunohistochemical, and genomic analyses of papillary renal neoplasm with reverse polarity.
Kiyozawa D; Kohashi K; Takamatsu D; Yamamoto T; Eto M; Iwasaki T; Motoshita J; Shimokama T; Kinjo M; Oshiro Y; Yonemasu H; Oda Y
Hum Pathol; 2021 Jun; 112():48-58. PubMed ID: 33811832
[TBL] [Abstract] [Full Text] [Related]
13. Tubulocystic renal cell carcinoma: Two-case report and literature review.
Xing S; Liu A; Yang X; Chen L; Xu D
Int J Immunopathol Pharmacol; 2021; 35():20587384211002966. PubMed ID: 33726547
[TBL] [Abstract] [Full Text] [Related]
14. [Metastatic renal cell carcinoma: a clinicopathological analysis of 196 cases].
Zhu Y; Han CH; Yang YL; Xu JJ; Yu YW
Zhonghua Bing Li Xue Za Zhi; 2020 Dec; 49(12):1255-1260. PubMed ID: 33287509
[No Abstract] [Full Text] [Related]
15. [Eosinophilic solid and cystic renal cell carcinoma with TSC2 gene mutations in children].
Yang WP; Chang KTE; Xu HY; Kuick CH; Ng EHQ; Huang H; Xiong F; Wu Y; Zeng ST; Fan JX; Loh XY
Zhonghua Bing Li Xue Za Zhi; 2020 Jul; 49(7):693-698. PubMed ID: 32610380
[No Abstract] [Full Text] [Related]
16. Comprehensive analysis of 34 MiT family translocation renal cell carcinomas and review of the literature: investigating prognostic markers and therapy targets.
Caliò A; Brunelli M; Segala D; Pedron S; Remo A; Ammendola S; Munari E; Pierconti F; Mosca A; Bollito E; Sidoni A; Fisogni S; Sacco C; Canu L; Sentinelli S; Fraccon AP; Fiorentino M; Scott C; Milella M; Porta C; Argani P; Martignoni G
Pathology; 2020 Apr; 52(3):297-309. PubMed ID: 32107074
[TBL] [Abstract] [Full Text] [Related]
17. [Xp11 neoplasma with melanocytic differentiation: a clinicopathological analysis].
Wang XT; Zhang RS; Li R; Ye SB; Wang X; Xia QY; Zhou XJ; Rao Q
Zhonghua Bing Li Xue Za Zhi; 2019 Dec; 48(12):945-950. PubMed ID: 31818068
[No Abstract] [Full Text] [Related]
18. A Clinicopathologic and Molecular Analysis of Fumarate Hydratase-deficient Renal Cell Carcinoma in 32 Patients.
Lau HD; Chan E; Fan AC; Kunder CA; Williamson SR; Zhou M; Idrees MT; Maclean FM; Gill AJ; Kao CS
Am J Surg Pathol; 2020 Jan; 44(1):98-110. PubMed ID: 31524643
[TBL] [Abstract] [Full Text] [Related]
19. Xp11.2 translocation renal neoplasm with features of TFE3 rearrangement associated renal cell carcinoma and Xp11 translocation renal mesenchymal tumor with melanocytic differentiation harboring NONO-TFE3 fusion gene.
Yu W; Wang Y; Rao Q; Jiang Y; Zhang W; Li Y
Pathol Res Pract; 2019 Sep; 215(9):152521. PubMed ID: 31277953
[TBL] [Abstract] [Full Text] [Related]
20. [Clinicopathological characteristics of fumarate hydratase-deficient renal cell carcinoma].
Zhang W; Chu J; Zou YW; Jiang YX; Wei ZM; Zhong DC; Liu Y; Li YJ; Yu WJ
Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):120-126. PubMed ID: 30695864
[No Abstract] [Full Text] [Related]
[Next]
